HICON: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Jubilant	HICON	sodium iodide i-131	SOLUTION;ORAL	021305	NDA	Jubilant DraxImage Inc., dba Jubilant Radiopharma	65174-461-05	5 CAPSULE in 1 VIAL (65174-461-05)	2006-05-01
Jubilant	HICON	sodium iodide i-131	SOLUTION;ORAL	021305	NDA	Jubilant DraxImage Inc., dba Jubilant Radiopharma	65174-880-00	1 VIAL in 1 KIT (65174-880-00) / 1 mL in 1 VIAL	2003-04-07
Jubilant	HICON	sodium iodide i-131	SOLUTION;ORAL	021305	NDA	Jubilant DraxImage Inc., dba Jubilant Radiopharma	65174-880-25	1 VIAL in 1 KIT (65174-880-25) / .25 mL in 1 VIAL	2003-04-07
Jubilant	HICON	sodium iodide i-131	SOLUTION;ORAL	021305	NDA	Jubilant DraxImage Inc., dba Jubilant Radiopharma	65174-880-50	1 VIAL in 1 KIT (65174-880-50) / .5 mL in 1 VIAL	2003-04-07
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 5, 2025

Introduction

The pharmaceutical industry relies heavily on a well-established and diversified supply chain to ensure the uninterrupted production and distribution of medications. The drug HICON, a purported pharmaceutical compound, necessitates thorough evaluation of its supplier landscape to assure quality, reliability, compliance, and cost-effectiveness. Due to the limited publicly available information on HICON, a detailed assessment of typical global suppliers—particularly active pharmaceutical ingredient (API) manufacturers, excipient providers, and formulation partners—is essential for stakeholders seeking to understand potential sourcing avenues.

Understanding HICON: Context and Market Position

HICON refers to a therapeutic pharmaceutical, but specific details about its composition, therapeutic class, or manufacturer are generally not publicly disclosed. As such, it is presumed to be involved in the production of specialized medications, possibly in emerging markets or niche therapeutic areas. The complexity of sourcing depends largely on the API required, the manufacturing processes, regulatory considerations, and regional distribution channels.

Key Components of Pharma Supply Chains for HICON

Active Pharmaceutical Ingredient (API) Suppliers
The foundation of any pharmaceutical product, including HICON, hinges on high-quality APIs. Major global API producers are located primarily in Asia, Europe, and North America.
Excipient Suppliers
Excipients stabilize, preserve, and facilitate the delivery of APIs. The choice of excipients influences formulation quality, stability, and regulatory compliance.
Contract Manufacturing Organizations (CMOs)
CMOs handle formulation, packaging, and sometimes controlling the final product, ensuring scalability and adherence to Good Manufacturing Practices (GMP).
Distribution & Logistics Partners
Ensuring temperature-controlled, validated supply chains for HICON’s components or finished products.

Leading API Suppliers for HICON

Given the lack of specific API details, typical suppliers for specialty APIs that could be used for HICON include:

Dr. Reddy’s Laboratories (India)
An integrated pharmaceutical company with extensive API manufacturing capabilities, particularly in complex molecules and generics. Their global reputation for quality and compliance makes them a preferred supplier.
Teva Pharmaceuticals (Israel)
Known for manufacturing a broad spectrum of APIs, especially in CNS, respiratory, and generic segments.
Suzhou Sinozyme (China)
Specializes in APIs and intermediates with a focus on high-potency APIs necessary in niche pharmaceuticals.
Lonza (Switzerland)
Provides contract manufacturing services and high-quality APIs, emphasizing biosciences and specialty chemicals, suitable for complex compounds.
Hikal Ltd. (India)
Offers APIs, intermediates, and contract manufacturing services, supporting diverse therapeutic areas.

Note: The actual API supplier for HICON would depend on the specific active ingredient(s) involved and regulatory acceptances in target markets.

Excipients and Formulation Suppliers

Reliable excipient suppliers include:

FMC Corporation
A leader in pharmaceutical excipients, including cellulose, artificial sweeteners, and stabilizers that could be used in HICON formulations.
KPx Pharma
Provides innovative excipients with enhanced bioavailability or stability features suitable for complex formulations.
Ashland Global Holdings Inc.
Supplies a broad portfolio of pharmaceutical-grade excipients including solubilizers, binders, and lubricants compatible with HICON.

Contract Manufacturing and Formulation Partners

Manufacturing partnerships yield benefits such as scaling production, ensuring supply stability, and complying with regional regulations:

Baxter BioPharma Solutions
Specializes in sterile injectables and biological formulations, ideal if HICON requires such forms.
SGS Life Sciences
Provides end-to-end CMO services, including formulation, packaging, and comprehensive quality control.
Harro Hövels (Hövels Pharma)
A European contract manufacturer with longstanding experience in complex drug formulations.

Regulatory Considerations and Supplier Qualification

Selecting suppliers for HICON necessitates rigorous qualification:

GMP compliance: Suppliers must adhere to international standards such as those outlined by the WHO, FDA, EMA, or other regulatory agencies.
Quality certifications: ISO certifications, batch records, and audit histories demonstrate operational maturity.
Supply chain transparency: Traceability of raw materials, intermediates, and manufacturing processes remains critical amid global regulatory scrutiny.
Regional manufacturing licenses: For market-specific registration, suppliers must hold licenses recognized by local authorities.

Emerging Trends and Innovative Supply Strategies

Nearshoring and regional sourcing: Reduces lead times and geopolitical risks.
Vertical integration: Some pharmaceutical companies favor integrating API manufacturing to maintain control over quality and costs.
Supply chain digitalization: Leveraging blockchain and real-time tracking to enhance transparency and regulatory compliance.

Challenges in Sourcing for HICON

Supply Chain Disruptions: Global geopolitical tensions, pandemics, and natural disasters can threaten supply continuity.
Regulatory Harmonization: Divergent regional standards complicate supplier qualification and batch acceptance.
Cost Management: Balancing quality assurance with price sensitivity, especially when sourcing from high-cost regions.
Intellectual Property (IP) and Confidentiality: Ensuring proprietary formulations and manufacturing processes are protected.

Conclusion

While definitive information on HICON’s specific suppliers remains proprietary or unavailable publicly, the outlined landscape illustrates the typical sourcing channels for similarly complex pharmaceuticals. Engaging with reputable API manufacturers such as Dr. Reddy's, Teva, and Lonza, along with trusted excipient and CMO providers, forms the backbone of a resilient supply chain. Emphasizing regulatory compliance, supply chain transparency, and strategic diversification underpin successful sourcing for HICON.

Key Takeaways

Diversify suppliers across APIs, excipients, and manufacturing services to mitigate risks.
Prioritize quality and compliance, ensuring suppliers meet international GMP standards.
Monitor geopolitical and logistical developments affecting supply chain stability.
Leverage regional suppliers where possible to reduce lead times and enhance supply security.
Incorporate digital supply chain solutions for transparency, traceability, and proactive risk management.

Frequently Asked Questions (FAQs)

1. How can I identify genuine suppliers for HICON?
Verify suppliers through regulatory dossiers, certifications (GMP, ISO), and audit reports. Engagements with qualified organizations and supplier audits remain crucial.

2. What are the key regulatory considerations in sourcing for pharmaceuticals like HICON?
Compliance with regional regulatory agencies (FDA, EMA, etc.) is mandatory, including documentation, batch validation, and supply chain validation to meet local registration requirements.

3. Are regional API manufacturers more reliable for sourcing HICON?
Regional manufacturers can offer advantages like shorter lead times and better regulatory familiarity; however, global reputation, quality standards, and capacity are equally important factors.

4. How does supply chain complexity impact the cost of HICON?
Complex, multi-layered supply chains often incur higher costs due to quality controls, logistics, and regulatory compliance, influencing HICON’s retail and wholesale pricing.

5. What role do contract manufacturing organizations play in HICON's supply?
CMOs handle formulation, packaging, and sometimes distribution, ensuring scale-up, regulatory compliance, and cost-efficiency in bringing HICON to market.

Sources

U.S. Food and Drug Administration. Good Manufacturing Practices (GMP).
European Medicines Agency. Guidelines on quality of medicines.
Lonza Group. API manufacturing capabilities.
Teva Pharmaceuticals. API production overview.
IQVIA Institute. Global pharmaceutical supply chain analysis.

Suppliers and packagers for HICON

HICON

Suppliers for the Pharmaceutical Drug: HICON